(Q40239588)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25455734%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

title

Survival differences of Asian and Caucasian epithelial ovarian cancer patients in the United States (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25455734%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25455734%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Jacob Y Shin

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25455734%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

author name string

Daniel S Kapp

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25455734%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Rebecca A Brooks

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25455734%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Stefanie Ueda

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25455734%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Renata R Urban

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25455734%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Lee-May Chen

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25455734%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

John K Chan

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25455734%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

language of work or name

English

0 references

publication date

16 October 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25455734%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25455734%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

volume

136

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25455734%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25455734%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

page(s)

491-497

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25455734%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

cites work

Cancer statistics, 2013

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.10.009

Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.10.009

Do racial/ethnic disparities exist in the utilization of high-volume surgeons for women with ovarian cancer?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.10.009

Ovarian cancer: changes in patterns at diagnosis and relative survival over the last three decades.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.10.009

Disparities in ovarian cancer care quality and survival according to race and socioeconomic status

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.10.009

Analysis of racial disparities in stage IIIC epithelial ovarian cancer care and outcomes in a tertiary gynecologic oncology referral center

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.10.009

Racial disparities in surgical treatment and survival of epithelial ovarian cancer in United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.10.009

Racial disparities in blacks with gynecologic cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.10.009

Predictors of comprehensive surgical treatment in patients with ovarian cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.10.009

Trends in surgery and chemotherapy for women diagnosed with ovarian cancer in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.10.009

Race/ethnic variations in ovarian cancer mortality in the United States, 1992-1997

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.10.009

Racial differences in stage at diagnosis and survival from epithelial ovarian cancer: a fundamental cause of disease approach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.10.009

Racial disparities and patterns of ovarian cancer surgical care in California

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.10.009

Patterns and progress in ovarian cancer over 14 years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.10.009

Long-term results of dose-dense paclitaxel and carboplatin versus conventional paclitaxel and carboplatin for treatment of advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer (JGOG 3016): a randomised, controlled, open-label tr

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.10.009

Carboplatin plus paclitaxel once a week versus every 3 weeks in patients with advanced ovarian cancer (MITO-7): a randomised, multicentre, open-label, phase 3 trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.10.009

Incorporation of bevacizumab in the primary treatment of ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.10.009

Cancer incidence trends among Asian American populations in the United States, 1990-2008

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.10.009

The treatment and outcomes of early-stage epithelial ovarian cancer: have we made any progress?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.10.009

Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.10.009

Ethnic differences in drug metabolism and toxicity from chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.10.009

Identification of BRCA1/2 founder mutations in Southern Chinese breast cancer patients using gene sequencing and high resolution DNA melting analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.10.009

Genetic anticipation of familial breast cancer with or without BRCA mutation in the Korean population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.10.009

Family history, BRCA mutations and breast cancer in Vietnamese women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.10.009

BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.10.009

Health status and hospital utilization of recent immigrants to New York City.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.10.009

All-cause and cause-specific mortality of immigrants and native born in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.10.009

The Latino mortality paradox: a test of the "salmon bias" and healthy migrant hypotheses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.10.009

Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer (The IDEAL 1 Trial) [corrected].

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.10.009

Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.10.009

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.10.009

Spectrum of cardiovascular diseases inAsian-American racial/ethnic subgroups

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.10.009

Type 2 diabetes: identifying high risk Asian American subgroups in a clinical population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.10.009

Racial/ethnic differences in dyslipidemia patterns

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.10.009

Integrated genomic analyses of ovarian carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.10.009

10.1016/J.YGYNO.2014.10.009

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25455734%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

1 reference